Bayer’s Gadavist has become the first imaging agent ... The magnetic resonance imaging (MRI) contrast agent – based on gadobutrol – has been cleared by the FDA for cardiac MRIs on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback